Contrast enhanced endoscopic ultrasound detects early therapy response following anti-TNF-therapy in patients with ulcerative colitis.
Mark EllrichmannBerenice SchulteClaudio C ConradStephan SchochJohannes BethgeMarcus SeegerRobert HuberMadita GoebAlexander ArltSusanna NikolausChristoph RoeckenStefan SchreiberPublished in: Journal of Crohn's & colitis (2024)
dCEUS enables the early detection of therapy response in patients with aUC, which serves as a predictive marker for long term clinical success. Therefore, dCEUS serves as a diagnostic tool for assessing the probability of future therapy success.